Back to search
Febrile Illness
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Febrile Illness trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Febrile Illness trials you may qualify forThis is a randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the efficacy, safety, and antiviral activity of CP-COV03 in adult patients wi…
The escalating environmental heat-stress associated with global warming is a societal challenge with large and potential harmful consequences for humans. Excess…
Approximately one million febrile infants aged ≤60 days present annually to pediatric emergency departments (PEDs) in Europe and the United States. Although few…
Streptococcus pneumoniae is responsible for serious infections associated to numerous hospitalizations and high rate of mortality. The incidence and therefore t…
The overall aim of the study is to provide evidence that introducing novel biomarkers evaluation at triaging (first clinical assessment), in combination with IM…
The epidemiology and outcome of febrile illnesses in the Democratic Republic of Congo (DRC) is poorly documented. The FIKI² study, a prospective observational s…
The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-5…
Febrile seizures occur in 2-5% of the population and are typically limited to children between 3 months and 5 years-of-age. The pathophysiological link between…
This study was designed as an experimental study with pre-test-post-test comparisons and control groups, in order to investigate the effects of salutogenic mode…